MAT

Pharmacological and Behavioral Treatment of Opioid Use Disorder

Scientific article

1 April 2019

Abstract Objective: Opioid use disorder (OUD) in the United States has surged, with an estimated 2.5 million needing treatment. The aim of this article is to provide a clinical overview of the key pharmacological and behavioral treatments...

Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville)

Scientific article

13 November 2014

Abstract Objective Methadone coverage is poor in many countries due in part to methadone induction being possible only in specialized care (SC). This multicenter pragmatic trial compared the effectiveness of methadone treatment between two...

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

Scientific article

28 July 2022

Abstract Background Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction...

The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance

Scientific article

19 May 2022

Abstract Background Evidence suggests people who inject drugs (PWID) prescribed opioid agonist treatment (OAT) are less likely to provide injection drug use (IDU) initiation assistance. We investigated the association between OAT engagement...

The Intersection of DEA, Opioids, and MAT

27 April 2022

Online

Wednesday, April 27, 2022 @ 3:00-4:00pm ET (2CT/1MT/12PT)

Description

As a result of the opioid crisis, more and more primary care providers are being asked to treat those suffering from opioid use disorder (OUD) through the use of medication assisted

The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya

Scientific article

15 February 2022

Abstract Background Cannabis use during methadone treatment may negatively impact treatment outcomes. The aim of this study was to determine the prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in...

An Interprofessional Approach to Providing Medication Treatment for Transitional Aged Youth with Opioid Use Disorder

19 May 2021

Washington DC

United States

Register now: https://register.gotowebinar.com/register/1407462158412714251

Wednesday, May 19, 2021, 2:00 PM - 3:00 PM ET (Washington, DC time)

The “Black Box” of Treatment: Patients’ Perspective on What Works in Opioid Maintenance Treatment for Opioid Dependence

Scientific article

10 May 2021

Source: Silva, T.C., Andersson, F.B. The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence. Subst Abuse Treat Prev Policy 16, 41 (2021). https://doi.org/10.1186/s13011-021...

Delivering Medication Assisted Treatment for Addictions via Telehealth

2 March 2021

Online

This seminar marks the launch of a consultation process funded by the Drug Deaths Task Force (DDTF), Scottish Government and Corra Foundation on best practice approaches on delivering

Geographic Proximity to Buprenorphine Treatment Providers in the U.S.

Scientific article

Abstract Objective To combat the growing opioid epidemic, people who use drugs need access to medications for opioid use disorder (MOUD) as part of comprehensive treatment. Despite progress, treatment gaps remain. Our objective was to use a...

MAT

Wednesday, April 27, 2022 @ 3:00-4:00pm ET (2CT/1MT/12PT)

Description

Register now: https://register.gotowebinar.com/register/1407462158412714251(link is external)

Register now: https://register.gotowebinar.com/register/1407462158412714251